A DECREASED OXYGEN SUPPLY, such as in cardiovascular disorders (e.g., congestive heart failure, ischemia), decreased oxygen transport capacity, pulmonary diseases (e.g., chronic obstructive pulmonary disease), and decreased inspired PO 2 , such as at high altitude, impairs cellular functions by decreasing cellular activity, metabolism, protein synthesis, and ion transport (21, 22, 36, 39, 40) . Mitochondrial respiration is decreased even at values of PO 2 between 10 and 60 mmHg, which do not limit mitochondrial respiration, a process termed "oxygen conformance" (21, 36) . These energy-sparing mechanisms are initiated within minutes of exposure to hypoxia. Below an extracellular PO 2 of about 10 mmHg (21) , cells become ATP depleted by a decrease in mitochondrial oxidative metabolism. These changes can cause dysfunction of mitochondria and ischemic or hypoxic cell injury with subsequent structural alterations (9) . The mechanisms causing these rapid changes are not fully understood.
After short-term exposure to hypoxia (15 min), decreased oxygen consumption and mitochondrial activity can fully be restored by a brief period of reoxygenation (21) . In contrast, we found that changes induced by 24 h of hypoxia are not readily reversible. This process might indicate decreased expression of genes encoding for enzymes involved in pathways with a high energy demand, as well as a decreased expression of mitochondrial enzymes. On the other hand, there is a stimulation of genes by the hypoxia-induced transcription factor (HIF) aimed at improving anaerobic metabolism and substrate supply, as well as restoring tissue oxygen supply (38) .
Hypoxia also decreases leukocyte oxygen consumption (14) . In contrast, leukocyte oxygen demand is increased when cells are stimulated by initiation of respiratory burst (14) , which increases leukocyte ROS production by NADPH oxidase (43) . Since this process requires oxygen, it might be impaired in hypoxia due to substrate limitation (14) . A decrease in nitroblue tetrazolium reduction (24) , decreased diacylglycerol formation, modulation of the PIP 2 -PLC pathway, and altered stimulation by interleukins (8) indicate impaired leukocyte function in hypoxia. Furthermore the respiratory burst of neutrophils has also been shown to decrease in hypoxia (14) , which was paralleled by a decreased activity of O 2 •Ϫ forming enzymes (14) . Subsequently, wound healing and bacterial killing might be impaired (2) . Hypoxia delays leukocyte apoptosis, a major mechanism resolving inflammation (19) , which might be due to a hypoxia-induced increase in macrophage inflammatory protein-1␤ (41) . It is unclear, however, whether impaired respiratory burst and delayed apoptosis are related processes. A decrease in ROS production in hypoxia has been found in other cell types as well (11, 30) . However, results are controversial since hypoxia has also been shown to induce the formation of oxygen radicals (ROS) by the mitochondrial electron transfer chain, at least when O 2 becomes very low (4) .
Most results on impaired leukocyte function were obtained during short-term, in vitro exposure to hypoxia. If these in vitro results apply to the in vivo situation, leukocyte function can be expected to be impaired in diseases and situations that are classically characterized by arterial hypoxemia. Using hypoxia of high altitude (4,559 m) as a model, we tested, therefore, whether in vivo hypoxia impairs leukocyte metabolism, mitochondrial function, and ROS production. To separate direct effects of hypoxia from systemic effects caused by highaltitude hypoxia, we compared these results with 24-h in vitro hypoxia of leukocytes collected from normoxic individuals. In both studies, cellular respiration and ROS production were also measured upon stimulation with PMA to test whether hypoxia affected the capacity of respiratory burst. All measurements were performed on cell suspensions equilibrated to a normoxic and hypoxic gas, which allows distinguishing effects of acute oxygen deprivation from adjustments caused by prolonged hypoxia.
MATERIALS AND METHODS
Chemicals/reagents. Ficoll-Paque plus was obtained from Amersham Biosciences (Uppsala, Sweden). HEPES was obtained from Gibco (Gibco, Karlsruhe, Germany). Rotenone, antimycin A, PMA, malate, glutamate, succinate, ADP, sucrose, and basic reagents were obtained from Sigma Chemicals (Sigma-Aldrich, Munich, Germany), and digitonin and fatty acid free BSA were obtained from Serva Chemicals (Serva, Heidelberg, Germany). Decylubiquinone was a gift from Dr. Okun (Children's Hospital, University of Heidelberg, Heidelberg, Germany).
Study population. Mountaineers (2 females, 13 males; 37 Ϯ 11 years) without and with previously documented high-altitude pulmonary edema (HAPE) and acute mountain sickness (AMS) were recruited through announcements in the journals of the Swiss and German Alpine Clubs and participated in this high-altitude study after written informed consent in a study on the pathophysiology of increased lung water at high altitude. They represent a subset of the individuals participating in a more extensive study on respiratory function at high altitude published recently (7). The study protocol was approved by the ethics committee of the University of Heidelberg. AMS was assessed using the Lake Louise Scoring System (32) , and the cerebral symptoms of AMS (AMS-C) score of the Environmental Symptoms Questionnaire (33) . AMS was diagnosed if subjects had a Lake Louise score of Ͼ4 and an AMS-C score of Ն0.70 in the morning of the second day at 4,559 m. HAPE was assessed by chest radiography (TRS, Siemens, Stockholm, Sweden) and clinical evaluation. None of the participants was considered preacclimatized since they did not spend more than 4 nights above 2,500 m within 30 days before the study at high altitude.
Baseline evaluations were performed in Heidelberg (110 m) 2 to 4 wk prior to high-altitude exposure. Subjects, in groups of three every 3 days, were transported by cable car to 3,200 m and then trekked to 3,611 m where they spent the night (Capanna Gnifetti). In the morning, they ascended to 4,559 m (Capanna Regina Margherita) with a certified mountain guide. At high altitude (HA), blood samples from one subject per arriving group was obtained for leukocyte preparation at ϳ0700 following the first overnight stay, which was ϳ20 h after arrival at 4,559 m.
Preparation of leukocytes. Blood (18 ml, anticoagulated with K-Edta, Sarstaedt, Germany) was collected via a central venous catheter inserted from the antecubital vein for leukocyte preparation and RNA isolation. Blood was centrifuged at 1,000 g at 4°C to remove plasma. The buffy coat was collected with Pasteur pipettes, suspended in 10 ml PBS and layered on top of 20 ml Ficoll-Paque plus (Amersham Biosciences) using 50-ml Falcon tubes. After centrifugation at 400 g for 30 min at 15°C, the supernatant was removed, and polymorphonuclear leukocytes were collected at the gradient interface, suspended in 40 ml PBS, and centrifuged at 400 g for 10 min at 4°C. Packed cells were suspended in a medium composed (in mM) of 135 NaCl, 5 KCl, 10 glucose, 1 Na 2HPO4, 1 MgCl2, 1 CaCl2, 10 HEPES, 1 mg/ml BSA, pH 7.4 at 37°C. This cell suspension was stored at 10°C until use for measurements of oxygen consumption and ROS production using respirometry and electron spin resonance (ESR) spectroscopy, respectively.
Respirometry. Mitochondrial oxygen consumption (JO 2) was measured in a respirometer using Clark-type electrodes (Oxygraph, OROBOROS Instruments, Innsbruck, Austria) at 37°C, as described previously (21) . JO 2 was calculated from the time derivative of the decrease in oxygen content in the closed chamber, which was corrected for the response time of the oxygen sensor and for instrumental background (back diffusion of oxygen, oxygen consumption by the oxygen sensor). JO2 was corrected for citrate synthase, an enzyme located in the mitochondrial matrix, which is commonly used as a marker for the cellular content of intact mitochondria (21, 23) .
Measurements of JO2 and ROS formation were performed at the same PO2 at low and at high altitude. "Normoxia" was defined as a PO2 of about 100 mmHg representing an average value of PO2 in arterial blood at low altitude. At low altitude, this was achieved by equilibrating the samples in the respirometer with a gas composed of 14% O2 and 86% N2 before closing the chamber. To achieve the same PO2 at high altitude, the gas contained 25% O2 and 75% N2. "Acute hypoxia" (PO2 ϭ 20 mmHg) during the measurement in the respirometer was introduced by decreasing the PO2 in the respirometer by equilibration with a gas composed of 2.8% O2 (97.2% N2) and 5% O2 and 95% N2 at low and high altitude, respectively. At this PO2, mitochondrial respiration is not oxygen limited (21) .
The same buffer as used for preparing cell suspensions was warmed to 37°C in the respirometer chamber and equilibrated with room air for calibration of the electrode. Cell suspension was added, and the PO2 was adjusted to 100 mmHg (normoxia) with the respective gas (see also Ref. 21) . Then, the system was closed to start the oxygen consumption measurement (JO2,100). After a stable reading was achieved, the chamber was opened, and the cell suspension was equilibrated with the respective hypoxic gas mix. Equilibration took about 5 min. The system was closed again to determine oxygen consumption in acute hypoxia (JO2,20). Measurements were repeated in cell suspensions to which PMA (200 nM final concentration) was added during equilibration with the normoxic gas in the respirometer. PMA is known to stimulate NADPH oxidase (43) .
Permeabilization of cells. In the altitude study, the activity of complexes I, II, and III of the mitochondrial electron transfer chain (mETC) was measured after permeabilization of the plasma membrane with the nonionic detergent digitonin to allow entry of complexspecific substrates (16, 20) . Permeabilization was performed in the cuvette of the respirometer by adding 5 g digitonin to 2.5 ml of cell suspension. This dose was evaluated in separate titration experiments by visualizing trypan blue staining and succinate-dependent respiration (not shown). Oxygen consumption was then measured in the presence of digitonin. The permeabilization medium contained (in mM) 75 sucrose, 100 KCl, 10 KH2PO4, 0.5 EDTA, 5 MgCl2, 20 Tris·HCl, and 1 mg/ml BSA (fatty acid free). Substrates and inhibitors of mitochondrial respiration were added as required to measure the activity of the mETC complexes I, II, and III at the following concentrations: 2 mM malate, 5 mM glutamate, 2 mM ADP, 2.5 M rotenone, 10 mM succinate, 50 M decylubiquinone, and 1 mM antimycin A (21) . Measurements were performed in normoxia and hypoxia as described above for intact cells.
Measurement of ROS formation by leukocytes.
Because leukocytes contribute to the respiratory burst, it was of importance to know whether acute exposure of the cells to in vitro hypoxia and exposure to high altitude would affect basal and PMA-stimulated ROS formation. The medium (in mM) 135 NaCl, 5 KCl, 10 glucose, 1 Na 2HPO4, 1 MgCl 2, 1 CaCl2, 10 HEPES, 1 mg/ml BSA, pH 7.4 at 37°C also contained 25 M desferrioxamine and 5 M diethyldithiocarbamate to control iron-dependent ROS formation during the incubation. Cells were prepared for oxygen consumption measurements, as described above, transferred to the respirometer, and equilibrated with normoxic gas in the absence and presence of 200 nM PMA. The cell-permeable spin probe CMH (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine; 500 M final concentration; Noxygen, Elzach, Germany) was added. Upon reaction with ROS, this spin probe is transformed into a stable CM
• radical that can be detected by X-band ESR spectroscopy (10) . An initial sample of the cell suspension (250 l) was transferred into a piece of a 1-ml plastic syringe, closed with Parafilm, and frozen immediately in liquid nitrogen. The respirometer was closed, and the cells were incubated for 10 min, during which time, oxygen consumption was also recorded. Then a second sample was taken and frozen immediately. Measurements and sampling were repeated in cells equilibrated to the hypoxic gas.
The CM • radical concentration was measured by ESR spectroscopy (26) . Spectra were recorded at Ϫ196°C using a benchtop ESR-spectrometer (MS200, Noxygen Science Transfer & Diagnostics) using the following settings: field sweep, 120 G; microwave frequency, 9.78 GHz; microwave power, 1 mW; modulation amplitude, 3 G; sweep time 120 s; receiver gain, 500. Frozen standard solutions were used for quantification (Noxygen Science Transfer & Diagnostics).
In vitro hypoxia. In a separate series of measurements, which were performed in Heidelberg only, leukocytes from individuals who did not participate in the high-altitude study and who were not exposed to hypoxia were prepared as described above (n ϭ 6). Cells were then suspended in RMPI containing 20 mm HEPES, penicillin, and streptomycin, and 10% FCS and were kept in tissue culture in normoxia and in normobaric hypoxia (1.5% O2, 5% CO2, rest N2) for 24 h. After incubation, cells were washed and suspended in buffer (see above) for respiration measurements. Extra-mitochondrial oxygen consumption was determined as an indicator of the activity of NADPH oxidase in the absence and presence of PMA after inhibition of complex I and complex III respiration. After equilibration with the normoxic gas, DMSO or PMA was added in the absence and presence of rotenone (0.5 M) and antimycin A (2.5 M), and oxygen consumption was recorded at a PO2 of 100 mmHg and 20 mmHg, as described above, to distinguish between mitochondrial and residual (extra-mitochondrial) oxygen consumption, the latter being used as a surrogate marker of NADPH oxidase.
Definitions. In this paper, the prefix CO-refers to the study on leukocytes from normoxic controls only, the prefixes LA-and HArefer to the measurements in the prealtitude and high-altitude test, respectively. The term JO2 is used to denote oxygen consumption measured with the respirometer. In either study, control and the high-altitude experiment, JO2 was measured after equilibrating the buffer in the respirometer to a normoxic gas to determine JO2 at a PO2 of 100 mmHg (JO2,100) and after equilibration to a hypoxic gas (PO2 ϭ 20 mmHg) to obtain JO2,20, independent of the altitude at which measurements were performed. Mitochondrial oxygen consumption in the control study was the proportion of JO2 inhibited by rotenone and antimycin A (CO-JO2,m,100 and CO-JO2,m,20). Residual oxygen consumption was the JO2 measured in the presence of rotenone and antimycin A (CO-JO2,res,100 and CO-JO2,res,20). Subscripts C1, C2, and C3 refer to the respiration of the complexes I, II, and III, respectively, of the mitochondrial electron transfer chain.
Biochemical analysis. For RT-PCR, cells obtained at low and high altitude were lyzed using the RLT reagent (Qiagen, Gaithersburg, MD, USA). Total RNA was isolated from the lysates with the RNeasy mini kit (Qiagen), according to the manufacturer's instructions. RNA (0.1 g) was transcribed with Superscript II reverse transcriptase (Invitrogen, Life Technologies, Darmstadt, Germany) using random hexamer primers (Roche, Mannheim, Germany). Real-time quantitative PCR was performed in the LightCycler (Roche). The QuantiTect SYBR Green PCR kit was used with QuantiTect primers for the detection of COX-1 and COX-2 (QuantiTect, Qiagen, Hilden, Germany). To test for the specificity of PCR amplification, PCR products were separated by agarose gel electrophoresis and stained with Gelstar (BMA, ME). PCR products showed single bands of the predicted size (not shown). Standards for quantification of PCR products were prepared by conventional PCR using the primers mentioned above and eluates of PCR products from agarose gels. 28S-rRNA was used to control for differences in the efficacy of reverse transcription.
Statistics. Results are shown as mean values Ϯ SD or SE of the number of experiments indicated in the figure legends. Statistical analysis was done by Student's t-tests, one-way ANOVA and Tukey post hoc tests using SigmaPlot (SYSTAT, Erkrath, Germany) as appropriate. Level of significance was P Յ 0.05.
RESULTS
From the individuals, whose leukocytes were studied, nine individuals had AMS; three of those also had HAPE. This relatively high incidence of HAPE is due to the fact that approximately half of the individuals whose leukocytes were studied were susceptible to HAPE. We analyzed whether altered leukocyte metabolism was related to severity of AMS. However, there was no correlation between leukocyte metabolism and the Lake Louise score or AMS-C (not shown).
Intact cells, high-altitude study. Citrate synthase (CS), a commonly used marker of mitochondrial density (23) , was used to normalize JO 2 . CS was 2.27 Ϯ 1.05 mU/ml of leukocyte suspension in low-altitude samples. It was increased significantly at high altitude (3.41 Ϯ 1.49; P ϭ 0.013). Since there was no possibility to obtain cell counts in the highaltitude laboratory, the difference in CS activity allows no conclusion on an altered number mitochondria or increased oxidative activity in the samples obtained at high altitude. JO 2,100 was 0.48 Ϯ 0.17 mol·s Ϫ1 ·unit Ϫ1 CS at low altitude. Figure 1 shows that JO 2, 20 at LA was about 40% lower than JO 2,100 at LA (P ϭ 0.002). JO 2,100 at HA was significantly decreased relative to low altitude (P ϭ 0.018). Acute hypoxia did not decrease JO 2,20 at HA further (P ϭ 0.241). Stimulation with PMA increased JO 2,100 both at low and high altitude (P ϭ 0.001), JO 2, 20 was increased at high altitude only (P ϭ 0.001). There was no difference between JO 2,100 at LA and HA (P ϭ 0.539) or JO 2,20 (P ϭ 0.469), respectively, when cells were stimulated with PMA.
Mitochondrial respiration, high-altitude study. Next, we tested whether the decreased oxygen consumption in acute hypoxia during the measurement of JO 2 and the hypoxia at high altitude was due to a decreased mitochondrial activity. Figure 2 summarizes results on complex-I, complex-II, and complex-III respiration. At low altitude, JO 2,C1,20 ( Fig. 2A) was ϳ55% lower than JO 2,C1,100 (P ϭ 0.005), at high altitude, JO 2,C1,20 was decreased by ϳ50% relative to JO 2,C1,100 (P ϭ 0.006). JO 2,C1,100 at HA was significantly lower than at LA (P ϭ 0.001), whereas JO 2,C1,20 was not different (P ϭ 0.162).
Also JO 2,C2,20 ( Fig. 2B ) was lower than JO 2,C2,100 at low altitude (Ϫ75%; P ϭ 0.001) and at high altitude (Ϫ70%; P ϭ 0.045). At high altitude, JO 2,C2,100 tended to be lower than the low-altitude value PO 2 ϭ 100 mmHg (P ϭ 0.074), whereas ascent to HA did not affect JO 2,C2,20 (P ϭ 0.988). JO 2,C3,100 was decreased at high altitude (P ϭ 0.017). JO 2,C3,20 was significantly lower than JO 2,C3,100 at low altitude (Ϫ40%; P ϭ 0.004; Fig.2C ), but there was no statistically significant effect of acute hypoxia at high altitude (P ϭ 0.557).
ROS formation, high-altitude study. Because leukocytes actively contribute to respiratory burst, it was important to know whether acute hypoxia and exposure to high altitude affect leukocyte ROS formation. The rate of production of ROS was measured during incubation in the respirometer using the spin probe CMH and ESR spectroscopy for detection of the stable CM
• radical. Figure 3 shows that neither acute hypoxia nor exposure to high altitude significantly affected ROS formation, although ROS formation in normoxia tended to be lower at high altitude (P ϭ 0.089). At a PO 2 of 100 mmHg, ROS formation was stimulated significantly with PMA in samples obtained at low and high altitude (P ϭ 0.001). When measured at a PO 2 of 20 mmHg, PMA increased ROS formation at high altitude (P ϭ 0.004), but there was only a trend toward an increase at low altitude (P ϭ 0.095).
In vitro study at low altitude. This series of in vitro experiments was performed to distinguish effects of hypoxia on leukocyte metabolism from possible systemic effects of high altitude. It was also aimed at testing to which extent PMAstimulated leukocyte metabolism comes from effects on mitochondria or extra-mitochondrial O 2 -consuming enzymes, such as NADPH oxidases (29), which we could not measure at high altitude. Extra-mitochondrial JO 2 (or residual JO 2 , res ) was measured in the absence and presence of rotenone and antimycin A to block complexes I and II. ROS were not measured in this experimental setting, since these inhibitors are known to stimulate ROS production. Figure 4 shows that in normoxia about 20% of total CO-JO 2,100 were inhibited by rotenone and antimycin A, indicating a significant contribution of JO 2 , res to Fig. 2 . Effects of acute hypoxia and high-altitude hypoxia on the activity of mitochondrial complexes I, II, and III. Leukocytes were prepared as described in Fig. 1 . Mitochondrial oxygen consumption (JO2) was measured after permeabilizing the cells with digitonin in a medium composed of (in mM) 75 sucrose, 225 mannitol, 10 KCl, 5 KH2PO4, 10 Tris·HCl, 1 mg/ml BSA (fatty acid-free), and 2 malate. State 3 respiration was initiated by adding ADP (2 mM). A: complex I respiration (JO2, C1) was measured in presence of 10 mM glutamate. B: complex II respiration (JO2,C2) was measured in presence of 10 mM succinate. C: substrate for complex III respiration (JO2,C3) was decylubiquinone (50 M). Because of the nature of decylubiquinone, sequential measurements were not possible, and separate measurements were performed in normoxia (PO2 ϭ 100 mmHg) and acute hypoxia (PO2 ϭ 20 mmHg). Mean values Ϯ SE from 12 to 15 samples. #Significant effect (P Ͻ 0.05) of acute hypoxia at the respective location; ϩSignificant difference (P Ͻ 0.05) between low and of high altitude. Fig. 1 . Effects of acute hypoxia and hypoxia at high altitude (4,559 m) on oxygen consumption (JO2) of leukocytes. Cells were isolated from whole blood by density gradient centrifugation in Heidelberg (110 m) and after ϳ20 h in the Capanna Margherita. The medium, which was composed of (in mM): 135 NaCl, 5 KCl, 10 glucose, 1 Na2HPO4, 1 MgCl2, 1 CaCl2, 10 HEPES, 1 mg/ml BSA, pH 7.4 at 37°C, was equilibrated in the respirometer to room air, and leukocytes were added. The oxygen content of the medium was adjusted to a normoxic PO2 (100 mmHg) by equilibration with the respective gas (see MATERIALS AND METHODS); then the system was closed to record JO2. The system was opened again to equilibrate with the hypoxic gas (PO2 ϭ 20 mmHg), and closed again to record JO2 in acute hypoxia. Measurements were performed in the absence and presence of PMA (200 nM whole cell JO 2 . Acute hypoxia decreased total JO 2 by about 65% (P Ͻ 0.001), and JO 2,res to 20% of the normoxic value (P Ͻ 0.001). The rotenone ϩ antimycin A inhibitable portion, JO 2,m decreased only slightly in acute hypoxia (P ϭ 0.579). As expected, PMA significantly increased total JO 2 and JO 2,res in normoxia and acute hypoxia. The degree of stimulation of both total JO 2 and extra-mitochondrial JO 2 was significantly lower in acute hypoxia. PMA also increased JO 2,m (P ϭ 0.013) when it was measured at a PO 2 ϭ 100 mmHg but not at a PO 2 ϭ 20 mmHg (P ϭ 0.178; Fig. 4 ). Figure 4 also shows that neither total JO 2 nor JO 2,res and JO 2,m measured at PO 2 ϭ 100 mmHg and 20 mmHg in the absence and presence of PMA were affected significantly by 24-h exposure to hypoxia. The only significant difference to cells exposed to normoxia for 24 h was that JO 2,m decreased to barely detectible values in the cells exposed to hypoxia for 24 h when it was measured at a PO 2 of 20 mmHg (P ϭ 0.013). Also, there was no statistically significant stimulation of JO 2,m by PMA in cells that had been exposed to in vitro hypoxia for 24 h (P ϭ 0.189).
The mRNA expression of COX-1 and COX-2 was measured as an indicator of possible hypoxia effects on leukocyte gene expression. We found that both COX-1 and COX-2 mRNA were increased significantly by ϳ50% (P ϭ 0.035) after 1 day at 4,559 m. In contrast, there was no statistically significant change in COX-1 and COX-2 in vitro (P ϭ 0.15). There was a significant, approximately three-fold increase in the plasma level IL-6 (P Ͻ 0.001) but no change in TNF-␣ (P ϭ 0.784) (not shown).
DISCUSSION
Hypoxia decreases the activity of oxygen-consuming pathways to conserve energy and to prevent cell death (37).
However, it also decreases cellular respiration (37) , which might impair cellular functions. Here, we studied whether leukocyte oxidative metabolism and the respiratory burst were affected by hypoxia in vivo and in vitro to separate direct hypoxia effects from systemic influences. Direct effects of hypoxia were studied by measuring cellular respiration in media equilibrated to hypoxic gas mixtures (total exposure time: ϳ15 min) and after culturing of leukocytes from nor- Fig. 4 . Effects of 24 h hypoxia and PMA on mitochondrial and residual oxygen consumption. Human leukocytes prepared from whole blood of normoxic individuals (n ϭ 6) by density gradient centrifugation were cultured in normoxia and hypoxia (1.5% O2) for 24 h. Oxygen consumption was measured in normoxia (PO2 ϳ100 mmHg) and in acute hypoxia (PO2 ϳ20 mmHg) in the absence and presence of 200 nmol PMA. A: total leukocyte oxygen consumption, JO2,tot. B: mitochondrial oxygen consumption (JO2,m) was determined as the proportion of JO2 inhibited by rotenone (0.5 M) and antimycin A (2.5 M). C: residual oxygen consumption (JO2,res) is the JO2 measured in presence of rotenone and antimycin A; it serves as a measure of O2 consumed by oxidases such as NADPH oxidase. Mean values Ϯ SD from measurements on six independent samples. Significant effect (#P Ͻ 0.05) of PMA. Significant effect (*P Ͻ 0.05) of acute hypoxia. Fig. 3 . Effects of acute hypoxia and hypoxia at high altitude (4,559 m) on leukocyte reactive oxygen species (ROS) production. Cells were prepared as for measurement of oxygen consumption (see Fig. 1 ) in the presence of 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH; 500 M) and equilibrated with normoxic and hypoxic gas. Aliquots (250 l) were collected at t ϭ 0 min, and 10 min later and immediately frozen in liquid nitrogen for CMH measurements by electron spin resonance spectroscopy. Measurements were performed in the absence and presence of 200 nM PMA. N, normoxia (PO2 ϭ 100 mmHg); H, hypoxia (PO2 ϭ 20 mmHg). Values are expressed as means Ϯ SD from 15 samples obtained at low altitude (110 m) and after ϳ24 h in the Capanna Regina Margherita (4,559 m). Significant effect (*P Ͻ 0.05) of PMA at the respective oxygenation and location. moxic individuals for 24 h in hypoxia. To test for systemic effects, measurements were performed on leukocytes from individuals exposed to high altitude. The major finding of this study was that acute in vitro hypoxia decreased oxygen consumption. Oxygen consumption was not different between cells cultured in normoxia or hypoxia for 24 h, regardless of the PO 2 at which it was measured. In contrast, oxygen consumption of leukocytes from individuals exposed to in vivo hypoxia at high altitude (4,559 m) was lower than prealtitude values when measured at normoxic PO 2 . This was paralleled by a decreased activity of complexes I, II, and III of the mitochondrial electron transfer chain. There was no difference between low and high altitude in JO 2, 20 . Respiratory burst induced with PMA was decreased by acute hypoxia but was not affected by 24 h of hypoxia when measured at a defined PO 2 . These results indicate that during high-altitude exposure, oxygen consumption of leukocytes was decreased by hypoxia directly but also by systemic effects. Decreased oxygen consumption is paralleled by lower mitochondrial respiration and by decreased respiratory burst.
Leukocyte metabolism in acute hypoxia. Acute hypoxia has been shown to inhibit cellular O 2 consumption by decreasing mitochondrial respiration in a variety of cells (see, e.g., 21, 22, 39) . Here, we show that in blood samples obtained from normoxic individuals acute in vitro hypoxia (PO 2 ϭ 20 mmHg) applied during the measurements of oxygen consumption significantly decreased basal leukocyte oxygen consumption relative to values obtained in simulated normoxia at a PO 2 of 100 mmHg. A decrease in JO 2 has been interpreted to reflect a decreased energy demand upon reducing the activity of ATPconsuming processes, such as Na/K-ATPase and protein synthesis (22) . Similar to alveolar epithelial cells (21) , we show here that in leukocytes the decrease in basal JO 2 was paralleled by a decrease in the capacity of complexes I and II of the mitochondrial electron transfer chain (mETC). Thus, in hypoxia, basal leukocyte oxygen consumption is decreased by a decrease in mitochondrial respiration.
Leukocytes are capable of respiratory burst that depends on the activity of NADPH oxidase. Since this enzyme directly uses O 2 to form O 2
•Ϫ (for review, see Ref. 18) , it is conceivable that hypoxia also decreases extramitochondrial oxygen consumption by a limitation of substrate (25) . We show here in accordance with Kozlov et al. (26) that stimulation of leukocytes with PMA increases ROS production and total JO 2 . Our results shown in Fig. 4 indicate that in nonstimulated leukocytes extra-mitochondrial oxygen consumption amounts to about 70% of total JO 2 , that PMA induced respiratory burst causes an increase in JO 2 , and that more than 80% of JO 2 is extra-mitochondrial upon stimulation with PMA. In support of our hypothesis, we show here that both basal and PMAstimulated extra-mitochondrial oxygen consumption was decreased by acute hypoxia. This supports the notion that a decrease in PO 2 also decreases oxidase activity (14) .
On the basis of the above described results and those obtained by Gabig et al. (14) , a decreased leukocyte ROS formation can also be expected in hypoxia, which should indicate impaired oxidative burst (8, 14) . Surprisingly, neither basal nor PMA-stimulated ROS formation was significantly affected by acute exposure to hypoxia. A likely explanation might be an inverse change in mitochondrial and NADPH oxidase-dependent ROS formation. An increased ROS formation by the mETC has been found in various cell types when the PO 2 was very low (4, 6) . Complexes II (31) and III (5) of the mETC have been discussed as possible sites of O 2
•Ϫ formation in hypoxia. In contrast, ROS formation by NADPH oxidase is decreased when the PO 2 is very low since it requires oxygen as a substrate. Thus, an unchanged rate of ROS formation might be the result of a decreased activity of NADPH oxidase and increased ROS formation in the mETC. This assumption implies that the relative contribution of mitochondrial and extramitochondrial ROS production determines the rate of ROS production measured in a specific cell at a given PO 2 , where the relative amounts or activities of NADPH oxidase and mitochondria is specific for a certain cell type. This might explain the discrepant results on ROS formation observed in hypoxia (e.g., 1, 35) .
Effects of prolonged in vitro hypoxia. In vitro hypoxia for 24 h of leukocytes collected from normoxic donors did not affect total JO 2 , regardless of the PO 2 at which JO 2 was measured. It tended to decrease mitochondrial JO 2 measured as the proportion of JO 2 inhibited by rotenone and antimycin A, whereas extra-mitochondrial JO 2 was not affected. As in normoxic cells, acute hypoxia applied in the respirometer significantly decreased total JO 2 also in the cells exposed to hypoxia for 24 h, whereas mitochondrial respiration dropped to barely detectible values (Fig. 4) . These results indicate that 24h of in vitro hypoxia seems not to impair leukocyte metabolism when measured at normoxic PO 2 but caused a pronounced decrease in mitochondrial JO 2 when cells are acutely hypoxic.
PMA increased total as well as mitochondrial JO 2 of hypoxic cells by the same degree as in normoxic ones, indicating that prolonged hypoxia of leukocytes did not affect the capacity of respiratory burst at a given PO 2 . PMA-stimulated JO 2 was lower in cells exposed to 24 h of in vitro hypoxia when measured at a PO 2 of 20 mmHg rather than at 100 mmHg, indicating that acute hypoxia impaired respiratory burst. We did not measure ROS production under these conditions since inhibition of complex I and III by treatment with rotenone and antimycin A, respectively, increases ROS production, which might affect other responses. However, results from separate test experiments (not shown) indicate parallel changes of ROS and JO 2 , indicating that extra-mitochondrial JO 2 is a suitable indicator of ROS formation. Taken together, these results indicate that in vitro hypoxia for 24 h seems not to impair cellular respiration and NADPH oxidase activity when measured at high PO 2 , whereas at low PO 2 , both components are decreased.
Effects of exposure to high altitude. It has been shown that the cell-proliferative activity and expression of proinflammatory cytokines were decreased after slow ascent and a 3-wk stay at high altitude (12) , which is indicative of impaired leukocyte function during prolonged in vivo hypoxia (12) . Further studies are needed, however, to discriminate whether these changes are due to hypoxia alone or whether systemic effects of hypoxia and the exercise during ascent also affected leukocytes. Exercise has been shown to stimulate immunecompetent cells as indicated by elevated expression of heat shock proteins (13) , but it has also been shown to be immunosuppressive by decreasing leukocyte counts and function (15) . Meehan et al. (28) reported a decrease in protein synthesis and thymidine uptake in mononuclear cells from blood samples obtained from individuals exposed to simulated extreme alti-tude during Operation Everest II. Here, we showed that the basal oxygen consumption was decreased in leukocytes collected from individuals ϳ24 h after reaching an altitude of 4,559 m, which was paralleled by a decrease in the activity of mETC-complexes I and III when measured at a PO 2 of 100 mmHg. Acute hypoxia of the leukocytes obtained at high altitude did not decrease total JO 2 but decreased complexes I and II. However, values were not different from those obtained in low-altitude cells acutely exposed to hypoxia. Basal ROS formation tended to decrease at high altitude, but PMA-stimulated ROS formation was not affected, regardless of the PO 2 at which it had been measured. This is also indicated by an unchanged oxygen consumption of PMA-stimulated leukocytes. It is unclear to what extent NADPH oxidase and other cytosolic oxidases might contribute to this result since no measure of extra-mitochondrial oxygen consumption could be obtained in the high-altitude study. These results indicate that cellular respiration of leukocytes was decreased after ascent to high altitude, whereas the capacity of respiratory burst was not impaired.
Recent studies suggest that hypoxia might initiate a systemic proinflammatory process by mediators released from lung alveolar macrophages (17) resulting in leukocyte activation (42) . This contrasts the observations described above. Our results on elevated mRNA expression of COX-1 and COX-2 in leukocytes collected at high altitude are also indicative of leukocyte stimulation. However, since COX expression was not altered by in vitro hypoxia, it appears that the increased COX expression is an effect secondary to the in vivo hypoxia at high altitude and, possibly, the exercise during ascent, but not a direct effect of the hypoxia.
The mechanisms causing the changes in leukocyte metabolism upon ascent to high altitude are not clear. Increased plasma levels of catecholamines at high altitude and with exertion (for review, see Ref.
3) might play a role since they are known to impair leukocyte function (34) . Decreased mitochondrial function might be a consequence of hypoxia-induced autophagy initiated by HIF-1␣, a well-known mechanism protecting cells from damage by elevated mitochondrial ROS production during severe hypoxia (37) . However, in an earlier study, at the same altitude and with the same profile of ascent, we found no indications for stimulation of HIF-1␣ in leukocytes indicated by unchanged mRNA expression of the glycolytic enzyme GAPD (27) , whose expression is up-regulated when HIF-1␣ is increased. This might indicate that, for leukocytes, the degree of hypoxia at this altitude is insufficient to increase HIF-1␣ activity (27) and that the changes observed are independent of HIF-1␣.
In conclusion, we show here that acute in vitro hypoxia decreased leukocyte metabolic activity and mitochondrial respiration. Thus, it can be speculated that leukocyte metabolism is decreased at high altitude when the PO 2 of blood is decreased. The fact that respiration of leukocytes was not affected by in vitro 24-h hypoxia but was decreased in leukocytes from individuals at high altitude when measured at normoxic PO 2 might indicate that systemic factors also appear to affect leukocyte metabolism and the respiratory burst in high-altitude hypoxia. This notion is further supported by our results showing that the mRNA expression of COX-1 and COX-2 in leukocytes was increased at high altitude but not by in vitro hypoxia. We cannot discriminate whether the exercise during ascent or systemic effects of hypoxia at high altitude itself caused this effect. PMA-stimulated oxygen consumption, a measure of the capacity of respiratory burst, and leukocyte ROS formation were not impaired in leukocytes from high altitude when measured at normoxic PO 2 . In contrast, acute hypoxia decreased respiratory burst. Thus, our results indicate that acute, severe hypoxia impairs leukocyte function at low and at high altitude.
